全文获取类型
收费全文 | 1087篇 |
免费 | 85篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 39篇 |
妇产科学 | 8篇 |
基础医学 | 150篇 |
口腔科学 | 7篇 |
临床医学 | 171篇 |
内科学 | 255篇 |
皮肤病学 | 25篇 |
神经病学 | 56篇 |
特种医学 | 47篇 |
外科学 | 167篇 |
综合类 | 1篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 55篇 |
眼科学 | 23篇 |
药学 | 52篇 |
肿瘤学 | 109篇 |
出版年
2023年 | 14篇 |
2022年 | 22篇 |
2021年 | 59篇 |
2020年 | 28篇 |
2019年 | 57篇 |
2018年 | 63篇 |
2017年 | 36篇 |
2016年 | 36篇 |
2015年 | 37篇 |
2014年 | 57篇 |
2013年 | 51篇 |
2012年 | 86篇 |
2011年 | 76篇 |
2010年 | 47篇 |
2009年 | 53篇 |
2008年 | 61篇 |
2007年 | 49篇 |
2006年 | 59篇 |
2005年 | 47篇 |
2004年 | 50篇 |
2003年 | 31篇 |
2002年 | 26篇 |
2001年 | 9篇 |
2000年 | 14篇 |
1999年 | 6篇 |
1998年 | 8篇 |
1997年 | 3篇 |
1996年 | 3篇 |
1995年 | 4篇 |
1994年 | 2篇 |
1993年 | 2篇 |
1992年 | 4篇 |
1991年 | 3篇 |
1990年 | 7篇 |
1989年 | 10篇 |
1988年 | 12篇 |
1987年 | 4篇 |
1986年 | 5篇 |
1985年 | 4篇 |
1984年 | 4篇 |
1983年 | 2篇 |
1981年 | 2篇 |
1977年 | 5篇 |
1973年 | 2篇 |
1972年 | 2篇 |
1967年 | 1篇 |
1965年 | 1篇 |
1964年 | 2篇 |
1962年 | 2篇 |
1960年 | 1篇 |
排序方式: 共有1175条查询结果,搜索用时 15 毫秒
61.
Florent F. Richy Soutrik Banerjee Yves Brabant Sandra Helmers 《Epilepsy & behavior : E&B》2009,16(2):240-245
The safety profiles of once-daily adjunctive levetiracetam (LEV) extended release (XR) (1000 mg/day) and adjunctive LEV immediate release (IR) (500 mg twice daily) were compared using data from three randomized, placebo (PBO)-controlled phase III clinical trials in patients with partial-onset seizures. MedDRA 9.0 treatment-emergent adverse events (TEAEs) were indirectly compared using meta-analytic techniques, including calculation of risk difference (RD) and mixed-effects analysis. Statistical significance was set at 10% alpha risk, the normative value for these analyses. Data from 555 patients older than 16 (204 LEV IR, 70 LEV XR, 281 PBO) were analyzed. Following adjustment for incidence of placebo TEAEs, LEV XR showed statistically significantly lower rates of TEAEs than LEV IR across nervous system disorders (RD = −18%, P = 0.03), psychiatric disorders (RD = −11%, P = 0.08), and metabolism and nutrition disorders (RD = −3%, P = 0.08). Among nervous system disorders, the RD for headache favored LEV XR (RD = −11%, P = 0.08). These results suggest that adjunctive LEV XR may be associated with a lower incidence of nervous system, psychiatric, and nutritional and metabolic TEAEs as compared with LEV IR. However, this difference was observed at a broad scale and not at a specific TEAE level except for headache. 相似文献
62.
63.
64.
Rougier F Claude D Maurin M Sedoglavic A Ducher M Corvaisier S Jelliffe R Maire P 《Antimicrobial agents and chemotherapy》2003,47(3):1010-1016
The main constraints on the administration of aminoglycosides are the risks of nephrotoxicity and ototoxicity, which can lead to acute, renal, vestibular, and auditory toxicities. In the present study we focused on nephrotoxicity. No reliable predictor of nephrotoxicity has been found to date. We have developed a deterministic model which describes the pharmacokinetic behavior of aminoglycosides (with a two-compartment model), the kinetics of aminoglycoside accumulation in the renal cortex, the effects of aminoglycosides on renal cells, the resulting effects on renal function by tubuloglomerular feedback, and the resulting effects on serum creatinine concentrations. The pharmacokinetic parameter values were estimated by use of the NPEM program. The estimated pharmacodynamic parameter values were obtained after minimization of the least-squares objective function between the measured and the calculated serum creatinine concentrations. A simulation program assessed the influences of the dosage regimens on the occurrence of nephrotoxicity. We have also demonstrated the relevancy of modeling of the circadian rhythm of the renal function. We have shown the ability of the model to fit with 49 observed serum creatinine concentrations for a group of eight patients treated for endocarditis by comparison with 49 calculated serum creatinine concentrations (r(2) = 0.988; P < 0.001). We have found that for the same daily dose, the nephrotoxicity observed with a thrice-daily administration schedule appears more rapidly, induces a greater decrease in renal function, and is more prolonged than those that occur with less frequent administration schedules (for example, once-daily administration). Moreover, for once-daily administration, we have demonstrated that the time of day of administration can influence the incidence of aminoglycoside nephrotoxicity. The lowest level of nephrotoxicity was observed when aminoglycosides were administered at 1:30 p.m. Clinical application of this model might make it possible to adjust aminoglycoside dosage regimens by taking into account both the efficacies and toxicities of the drugs. 相似文献
65.
Neutrophil derived CSF1 induces macrophage polarization and promotes transplantation tolerance 下载免费PDF全文
Mounia S. Braza Patricia Conde Mercedes Garcia Isabel Cortegano Manisha Brahmachary Venu Pothula Francois Fay Peter Boros Sherry A. Werner Florent Ginhoux Willem J. M. Mulder Jordi Ochando 《American journal of transplantation》2018,18(5):1247-1255
The colony‐stimulating factor 1 (CSF1) regulates the differentiation and function of tissue macrophages and determines the outcome of the immune response. The molecular mechanisms behind CSF1‐mediated macrophage development remain to be elucidated. Here we demonstrate that neutrophil‐derived CSF1 controls macrophage polarization and proliferation, which is necessary for the induction of tolerance. Inhibiting neutrophil production of CSF1 or preventing macrophage proliferation, using targeted nanoparticles loaded with the cell cycle inhibitor simvastatin, abrogates the induction of tolerance. These results provide new mechanistic insights into the developmental requirements of tolerogenic macrophages and identify CSF1 producing neutrophils as critical regulators of the immunological response. 相似文献
66.
We have analyzed Y-chromosome variation in a large sample of males from Western Europe by surveying p49a,f TaqI polymorphisms. Haplotype XV (A3, Cl, D2, Fl, Il) is the main Y-chromosome haplotype in West Europe, with a Basque focus in Southwestern Europe. This study demonstrates that the geographic distribution of Y-chromosome variation for p49a,f TaqI haplotype XV reveals an important genetic identity for populations that live in the Occidental part of Europe. 相似文献
67.
Adrien Picod Agnès Bonnin Giorgia Battipaglia Federica Giannotti Annalisa Ruggeri Eolia Brissot Florent Malard Clémence Médiavilla Ramdane Belhocine Anne Vekhoff Mor Sény Gueye Simona Lapusan Rosa Adaeva Françoise Isnard Ollivier Legrand Minh-Tam Baylatry Anne-Christine Joly Myriam Labopin Mohamad Mohty 《Biology of blood and marrow transplantation》2018,24(7):1471-1475
Sinusoidal obstruction syndrome (SOS), also known as hepatic veno-occlusive disease (VOD), is a serious complication after hematopoietic stem cell transplantation (HSCT). SOS/VOD usually occurs within 3 weeks of HSCT, but the 2016 European Society for Blood and Marrow Transplantation diagnosis criteria have been revised to include late forms. Prophylactic use of defibrotide is recommended in the pediatric setting, but its value remains uncertain in the adult population. We report here a single-center series of 63 adult patients considered at high risk for SOS/VOD who received defibrotide prophylaxis in combination with ursodeoxycholic acid between May 2012 and August 2016. The median duration of defibrotide therapy was 23 days. Bleeding occurred in 14 patients (21.5%). Defibrotide prophylaxis was discontinued in 7 patients (10.8%): 4 cases (6.3%) due to bleeding and 3 cases (4.6%) because of the need for antithrombotic therapy. Overall, SOS/VOD occurred in 4 cases (6.3%) within 21 days after HSCT (days 13 and 14) in 2 cases and late-onset SOS/VOD (days 57 and 58) in the other 2 cases. SOS/VOD was moderate in 1 case, very severe in 3 cases, with 2 deaths related to SOS/VOD. Cumulative incidence of grades II to IV acute graft-versus-host disease and transplant-associated thrombotic microangiopathy were 22.2% and 3.2%, respectively. With a median follow-up of 31 months (range, 10.7 to 60.3), the rates of 2-year overall survival, progression-free survival, incidence of relapse, and nonrelapse mortality were 56.5%, 49%, 28.7%, and 22.3%, respectively. In our experience defibrotide prophylaxis is associated with a low incidence of SOS/VOD after allogeneic HSCT in a high-risk adult population with an acceptable safety profile. 相似文献
68.
69.
70.
Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects 总被引:3,自引:0,他引:3
Borg C Terme M Taïeb J Ménard C Flament C Robert C Maruyama K Wakasugi H Angevin E Thielemans K Le Cesne A Chung-Scott V Lazar V Tchou I Crépineau F Lemoine F Bernard J Fletcher JA Turhan A Blay JY Spatz A Emile JF Heinrich MC Mécheri S Tursz T Zitvogel L 《The Journal of clinical investigation》2004,114(3):379-388
Mutant isoforms of the KIT or PDGF receptors expressed by gastrointestinal stromal tumors (GISTs) are considered the therapeutic targets for STI571 (imatinib mesylate; Gleevec), a specific inhibitor of these tyrosine kinase receptors. Case reports of clinical efficacy of Gleevec in GISTs lacking the typical receptor mutations prompted a search for an alternate mode of action. Here we show that Gleevec can act on host DCs to promote NK cell activation. DC-mediated NK cell activation was triggered in vitro and in vivo by treatment of DCs with Gleevec as well as by a loss-of-function mutation of KIT. Therefore, tumors that are refractory to the antiproliferative effects of Gleevec in vitro responded to Gleevec in vivo in an NK cell-dependent manner. Longitudinal studies of Gleevec-treated GIST patients revealed a therapy-induced increase in IFN-gamma production by NK cells, correlating with an enhanced antitumor response. These data point to a novel mode of antitumor action for Gleevec. 相似文献